Company Description
NeuroPace, Inc. operates as a medical device company in the United States.
The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy.
Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories.
In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions.
It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures.
NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
| Country | United States |
| Founded | 1997 |
| IPO Date | Apr 22, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 209 |
| CEO | Joel Becker |
Contact Details
Address: 455 North Bernardo Avenue Mountain View, California 94043 United States | |
| Phone | 650 237 2700 |
| Website | neuropace.com |
Stock Details
| Ticker Symbol | NPCE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $17.00 |
| CIK Code | 0001528287 |
| CUSIP Number | 641288105 |
| ISIN Number | US6412881053 |
| Employer ID | 22-3550230 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Joel D. Becker | Chief Executive Officer, President and Director |
| Dr. Martha J. Morrell M.D. | Chief Medical Officer |
| Rebecca L. Kuhn | Advisor |
| Patrick F. Williams | Chief Financial Officer |
| Dylan St. John | Chief of Operations and Development |
| Scott R. Schaper | Head of Investor Relations |
| Leah Akin | General Counsel and Corporate Secretary |
| Katie Keller | Vice President of Marketing |
| Chris Reese | Senior Vice President of Sales |
| Amy Treadwell | Vice President of Human Resources |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 21, 2026 | ARS | Filing |
| Apr 21, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 21, 2026 | DEF 14A | Other definitive proxy statements |
| Mar 3, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 3, 2026 | 10-K | Annual Report |
| Mar 3, 2026 | 8-K | Current Report |
| Dec 15, 2025 | 144 | Filing |
| Nov 7, 2025 | SCHEDULE 13G/A | Filing |
| Nov 4, 2025 | 10-Q | Quarterly Report |
| Nov 4, 2025 | 8-K | Current Report |